We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Different Metabolic Characteristics in the Presence of Brown Adipose Tissue in Humans

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01430338
First Posted: September 8, 2011
Last Update Posted: March 17, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
K. M. Choi, Korea University
August 24, 2011
September 8, 2011
March 17, 2015
December 2010
December 2011   (Final data collection date for primary outcome measure)
presence metabolic syndrome [ Time Frame: 5 months ]
Same as current
Complete list of historical versions of study NCT01430338 on ClinicalTrials.gov Archive Site
  • BMI [ Time Frame: 5 months ]
  • visceral fat area [ Time Frame: 5 months ]
  • adipokines [ Time Frame: 5 months ]
  • sarcopenia [ Time Frame: 5 months ]
  • BMI [ Time Frame: 5 months ]
  • visceral fat area [ Time Frame: 5 months ]
  • adipokines [ Time Frame: 5 months ]
Not Provided
Not Provided
 
Different Metabolic Characteristics in the Presence of Brown Adipose Tissue in Humans
Different Metabolic Characteristics in the Presence of Brown Adipose Tissue in Humans
Functional brown adipose tissue (BAT) exists in adult humans and can be detected by PET and especially during acute cold exposure. It is conceivable that BAT activity might reduce the risk of developing obesity since fat stores are used for thermogenesis, and a directed enhancement of adipocyte metabolism might have value in weight reduction. So it is important to know the different metabolic characteristics in human adults who have detected BAT. Therefore, the purpose of the investigators study is to compare different metabolic characteristics in the presence of brown adipose tissue in humans.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Retention:   Samples Without DNA
Description:
plasma and serum
Probability Sample
Patients who underwent 18FDG-PET/CT scan year between 2008-2010.
Metabolic Syndrome
Not Provided
BAT
brown adipose tissue detected, undetected
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
90
Not Provided
December 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients who underwent 18FDG-PET/CT scan year between 2008-2010

Exclusion Criteria:

  • History of cardiovascular disease (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
  • Diabetes
  • Stage 2 hypertension
  • Severe renal or hepatic disease
Sexes Eligible for Study: Female
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT01430338
BAT
Yes
Not Provided
Not Provided
K. M. Choi, Korea University
Korea University
Not Provided
Not Provided
Korea University
September 2011